523 related articles for article (PubMed ID: 28487045)
1. Pentraxin 3 levels in bronchoalveolar lavage fluid of lung transplant recipients with invasive aspergillosis.
Kabbani D; Bhaskaran A; Singer LG; Bhimji A; Rotstein C; Keshavjee S; Liles WC; Husain S
J Heart Lung Transplant; 2017 Sep; 36(9):973-979. PubMed ID: 28487045
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
[TBL] [Abstract][Full Text] [Related]
3. Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients.
Bhimji A; Bhaskaran A; Singer LG; Kumar D; Humar A; Pavan R; Lipton J; Kuruvilla J; Schuh A; Yee K; Minden MD; Schimmer A; Rotstein C; Keshavjee S; Mazzulli T; Husain S
Clin Microbiol Infect; 2018 Jun; 24(6):640-645. PubMed ID: 28970160
[TBL] [Abstract][Full Text] [Related]
4. The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis.
He Q; Zhang M; Feng C
BMC Pulm Med; 2021 Dec; 21(1):414. PubMed ID: 34915889
[TBL] [Abstract][Full Text] [Related]
5. A strategy for prevention of fungal infections in lung transplantation: Role of bronchoalveolar lavage fluid galactomannan and fungal culture.
Husain S; Bhaskaran A; Rotstein C; Li Y; Bhimji A; Pavan R; Kumar D; Humar A; Keshavjee S; Singer LG
J Heart Lung Transplant; 2018 Jul; 37(7):886-894. PubMed ID: 29548625
[TBL] [Abstract][Full Text] [Related]
6. Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis.
Luong ML; Chaparro C; Stephenson A; Rotstein C; Singer LG; Waters V; Azad S; Keshavjee S; Tullis E; Husain S
Transplantation; 2014 Feb; 97(3):351-7. PubMed ID: 24305637
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
8. Pentraxin 3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with pulmonary aspergillosis.
Li H; Liu L; Zhou W; Rui Y; He B; Shi Y; Su X
Clin Microbiol Infect; 2019 Apr; 25(4):504-510. PubMed ID: 29964232
[TBL] [Abstract][Full Text] [Related]
9. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
[TBL] [Abstract][Full Text] [Related]
10. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.
Husain S; Paterson DL; Studer SM; Crespo M; Pilewski J; Durkin M; Wheat JL; Johnson B; McLaughlin L; Bentsen C; McCurry KR; Singh N
Transplantation; 2007 May; 83(10):1330-6. PubMed ID: 17519782
[TBL] [Abstract][Full Text] [Related]
11. PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis.
Chong GM; van der Beek MT; von dem Borne PA; Boelens J; Steel E; Kampinga GA; Span LF; Lagrou K; Maertens JA; Dingemans GJ; Gaajetaan GR; van Tegelen DW; Cornelissen JJ; Vonk AG; Rijnders BJ
J Antimicrob Chemother; 2016 Dec; 71(12):3528-3535. PubMed ID: 27530755
[TBL] [Abstract][Full Text] [Related]
12. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
[TBL] [Abstract][Full Text] [Related]
13. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients.
Tabarsi P; Soraghi A; Marjani M; Zandian P; Baghaei P; Najafizadeh K; Droudinia A; Sarrafzadeh SA; Javanmard P; Mansouri D
Exp Clin Transplant; 2012 Jun; 10(3):278-81. PubMed ID: 22631066
[TBL] [Abstract][Full Text] [Related]
16. Invasive pulmonary aspergillosis in heart transplant recipients.
Küpeli E; Ulubay G; Bayram Akkurt S; Öner Eyüboğlu F; Sezgin A
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():352-5. PubMed ID: 25894189
[TBL] [Abstract][Full Text] [Related]
17. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
Danpornprasert P; Foongladda S; Tscheikuna J
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
[TBL] [Abstract][Full Text] [Related]
18. (1,3) β-D-Glucan in Bronchoalveolar Lavage of Lung Transplant Recipients for the Diagnosis of Invasive Pulmonary Aspergillosis.
Bhaskaran A; Kabbani D; Singer LG; Prochnow T; Bhimji A; Rotstein C; Finkelman MA; Keshavjee S; Husain S
Med Mycol; 2017 Feb; 55(2):173-179. PubMed ID: 27486213
[TBL] [Abstract][Full Text] [Related]
19. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
[TBL] [Abstract][Full Text] [Related]
20. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
